Mirtazapine alters cue-associated methamphetamine seeking in rats.

Mirtazapine alters cue-associated methamphetamine seeking in rats.
复制标题

Mirtazapine改变了在大鼠中寻求与提示相关的甲基苯丙胺。

DOI:
10.1016/j.biopsych.2010.09.032
复制
发表时间:
2011-02-01
影响因子:
10.6
通讯作者:
Napier, T. Celeste
Napier, T. Celeste
中科院分区:
医学1区
文献类型:
--
作者:
Graves, Steven M.;Napier, T. Celeste

文献摘要

参考文献

被引文献

相似文献

甲基苯丙胺(METH)是一种强效精神兴奋剂,重复使用可导致药物滥用障碍。退缩的人很容易复发,这可能是驱动的,至少部分是由一个高反应的METH相关的线索,可以促使METH寻求。目前迫切需要确定临床有效的药物治疗甲基苯丙胺滥用。米氮平(Remeron®)是一种非典型抗抑郁药,可拮抗活化的去甲肾上腺素α2、组胺1-羟色胺(5-HT)2A/C和5-HT 3受体。这种药理学特征促使我们对其预防复发的潜力感兴趣。目前的研究测试了假设,米氮平会减弱训练自我管理的大鼠的甲基苯丙胺寻求。大鼠接受训练,以在压迫性操作任务中自我施用METH。米氮平对寻求甲基的影响是通过评估杠杆压在存在的线索,以前与甲基有关,但在没有甲基强化。使用了两种范例:提示反应性,其中大鼠不经历灭绝训练,以及灭绝后提示诱导的恢复范例。米氮平(5.0mg/kg)预处理在线索反应性和线索诱导的恢复测试的前15分钟内减少了约50%的METH寻求。该米氮平剂量对运动表现无显著影响。这项研究揭示了线索反应性和线索诱导的恢复程序的重叠性质,并提供了临床前证据表明,米氮平可以减弱寻求甲基苯丙胺的行为。
Methamphetamine (METH) is a potent psychostimulant, repeated use of which can result in a substance abuse disorder. Withdrawn individuals are highly prone to relapse which may be driven, at least in part, by a hyper-responsivity to METH-associated cues that can prompt METH-seeking. There is a critical need to identify clinically efficacious pharmacotherapies for METH abuse. Mirtazapine (Remeron®) is an atypical antidepressant, that antagonizes activated norepinephrineα2, histamine1 serotonin (5-HT)2A/C, and 5-HT3 receptors. This pharmacological profile prompted our interest in its potential for preventing relapse to METH-taking. The current study tested the hypothesis that mirtazapine would attenuate METH-seeking in rats trained to self-administer METH. Rats were trained to self-administer METH in a lever-pressing operant task. The effect of mirtazapine on METH-seeking was determined by evaluating lever pressing in the presence of cues previously associated with METH, but in the absence of METH reinforcement. Two paradigms were utilized: cue reactivity, wherein rats do not undergo extinction training, and a cue-induced reinstatement paradigm after extinction. Mirtazapine (5.0mg/kg) pretreatment reduced METH-seeking by ~50% in the first 15min of cue reactivity and cue-induced reinstatement testing. This mirtazapine dose did not significantly impact motor performance. This study revealed the overlapping nature of cue reactivity and cue-induced reinstatement procedures and provided preclinical evidence that mirtazapine can attenuate METH-seeking behavior.
DOI: 10.1007/s002130000676
发表时间: 2001-04-01
期刊: PSYCHOPHARMACOLOGY
影响因子: 3.4
作者:
Baker, DA;Tran-Nguyen, LTL;Neisewander, JL
通讯作者: Neisewander, JL
DOI: 10.1046/j.1471-4159.1999.0731033.x
发表时间: 1999-09-01
影响因子: 4.7
作者:
De Deurwaerdère, P;Spampinato, U
通讯作者: Spampinato, U
DOI: 10.1016/s0028-3908(99)00047-7
发表时间: 1999-08-01
期刊: NEUROPHARMACOLOGY
影响因子: 4.7
作者:
Di Matteo, V;Di Giovanni, G;Esposito, E
通讯作者: Esposito, E
DOI: 10.1007/s002130050402
发表时间: 1997-10-01
期刊: PSYCHOPHARMACOLOGY
影响因子: 3.4
作者:
Berendsen, HHG;Broekkamp, CLE
通讯作者: Broekkamp, CLE
DOI: 10.1016/0028-3908(94)90081-7
发表时间: 1994-03-01
期刊: NEUROPHARMACOLOGY
影响因子: 4.7
作者:
KOOYMAN, AR;ZWART, R;VIJVERBERG, HPM
通讯作者: VIJVERBERG, HPM